Iron powder
Iron powder is a mineral ingredient obtained through chemical synthesis. It acts as an opacifying agent in cosmetic formulations.
Roles & functions
Opacifying — Makes the product less transparent.
Safety limit not to exceed
| Population | Limit / day | Type of reference | Source |
|---|---|---|---|
| Adult · general population | 40 mg | Safe level of intake | EFSA NDA 2024 (EFSA J 22(6):8819) |
| Pregnancy | 40 mg | Safe level of intake | EFSA NDA 2024 (EFSA J 22(6):8819) |
| Breastfeeding | 40 mg | Safe level of intake | EFSA NDA 2024 (EFSA J 22(6):8819) |
| From 0 months to 11 months | 5 mg · supplemental intake | Safe level of intake | EFSA NDA 2024 (EFSA J 22(6):8819) |
| From 12 months to 47 months | 10 mg | Safe level of intake | EFSA NDA 2024 (EFSA J 22(6):8819) |
| From 4 years to 83 months | 15 mg | Safe level of intake | EFSA NDA 2024 (EFSA J 22(6):8819) |
| From 7 years to 131 months | 20 mg | Safe level of intake | EFSA NDA 2024 (EFSA J 22(6):8819) |
| From 11 years to 179 months | 30 mg | Safe level of intake | EFSA NDA 2024 (EFSA J 22(6):8819) |
| From 15 years to 215 months | 35 mg | Safe level of intake | EFSA NDA 2024 (EFSA J 22(6):8819) |
Official reference limit, for information only, this is not personalised advice. Ask a pharmacist about your situation.
Last verified :
What the authorities say
| Authority | Status |
|---|---|
| Commission européenne (CosIng, Règl. 1223/2009) | Autorisé |
| CLP classification (Reg. 1272/2008) | No CMR classification |
| ECHA — endocrine disruptor (human health) | Not identified as an endocrine disruptor |
| ECHA — Candidate List (SVHC, REACH Art. 59) | Not on the Candidate List (SVHC) |
| European Commission (Reg. 1223/2009, Annex III) | No cosmetic allergen subject to mandatory labelling |
| European Commission (EU catalogue of nanomaterials, Reg. 1223/2009) | No referenced nanoform |
What the EFSA says
Yes. Iron contributes to normal cognitive development of children
Yes. Iron contributes to normal cognitive function
Yes. Iron contributes to normal energy-yielding metabolism
Yes. Iron contributes to normal formation of red blood cells and haemoglobin
Yes. Iron contributes to normal oxygen transport in the body
Yes. Iron has a role in the process of cell division
Yes. Iron contributes to the normal function of the immune system
Yes. Iron contributes to the reduction of tiredness and fatigue
Source: EFSA / Reg. (EU) 432/2012
No contraindication is specified to date for this ingredient.
Products containing it
In Lou’s database
| Most frequent categories | Support & compression |
| Most frequent brands | ThermCool et Hot |
A question about this ingredient?
Lou answers you and looks at your products with you, in store.